Peptides

Gonadorelin

A GnRH medicine with specific diagnostic and specialist reproductive uses; the clinical purpose and delivery method matter.

UK diagnostic label; observational fertility evidence

Also known as: GnRH

Gonadorelin molecular structure — Structure reference · C55H75N17O13

Practical use

Reviewed practical notes

Keep the indication: Diagnostic testing and ongoing reproductive treatment are different uses.
Check the denominator: A per-course live-birth rate is not a per-cycle probability.
Review other medicines: Hormone-active treatment can affect both test interpretation and the clinical plan.

2022 fertility cohort

UK gonadorelin human prescribing information

Overview

Gonadorelin stimulates pituitary release of luteinizing hormone and follicle-stimulating hormone. The cited UK product label describes diagnostic testing of pituitary gonadotropin function. A hormonal response during a test is different from demonstrating a successful fertility treatment.

Risks and limitations

The UK label identifies hypersensitivity risk, restrictions in pregnancy and warnings about pituitary tumors, including pituitary apoplexy. Other hormone-active medicines can affect interpretation of the diagnostic response. Specialist assessment is part of this medicine’s clinical use.

How to read this

Pulsatile GnRH treatment has also been studied for infertility associated with functional hypothalamic amenorrhea. That selected population and delivery system cannot establish a routine fertility-preservation benefit alongside testosterone or other hormone use.

Research explained

Long-term clinic cohort in hypothalamic amenorrhea

Who was studied

66 women receiving 82 treatment courses across 212 cycles in a retrospective, single-center cohort.

What was found

The report found high ovulation rates and a 65.9% live-birth rate per treatment course.

What it cannot establish

This was not randomized. Live births per treatment course, pregnancies and ovulations per cycle have different denominators; the result cannot be applied to every cause of infertility.

Read the original study

A diagnostic response has a limited meaning

A normal response can show functioning pituitary gonadotropes. The UK label explicitly says the single-injection test does not determine the cause of a subnormal response or measure pituitary gonadotropic reserve.

Supporting source

Authorization belongs to a product and jurisdiction

This guide cites a UK human diagnostic label. A similarly named veterinary product or a fertility study in another setting does not establish the same approved indication everywhere.